President and CEO
Nammi Therapeutics, Inc.
Los Angeles California UNITED STATES
Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development. Most recently at Astellas where he was site head of the Oncology Biologics Affiliate, Agensys, and was responsible for Research, GMP manufacturing, regulatory, Clinical Development, IP, Regulatory, and Finance functions. Previously Dr. STover lead research groups at Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.